201 related articles for article (PubMed ID: 24671095)
1. Metabolic syndrome increases risk of Barrett esophagus in the absence of gastroesophageal reflux: an analysis of SEER-Medicare Data.
Drahos J; Ricker W; Parsons R; Pfeiffer RM; Warren JL; Cook MB
J Clin Gastroenterol; 2015 Apr; 49(4):282-8. PubMed ID: 24671095
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome and risk of esophageal adenocarcinoma in elderly patients in the United States: An analysis of SEER-Medicare data.
Drahos J; Ricker W; Pfeiffer RM; Cook MB
Cancer; 2017 Feb; 123(4):657-665. PubMed ID: 27861759
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome in relation to Barrett's esophagus and esophageal adenocarcinoma: Results from a large population-based case-control study in the Clinical Practice Research Datalink.
Drahos J; Li L; Jick SS; Cook MB
Cancer Epidemiol; 2016 Jun; 42():9-14. PubMed ID: 26972225
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome is associated with higher rate of gastroesophageal reflux disease: a meta-analysis.
Fu S; Xu M; Zhou H; Wang Y; Tan Y; Liu D
Neurogastroenterol Motil; 2022 May; 34(5):e14234. PubMed ID: 34378835
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and predictors of columnar lined esophagus in gastroesophageal reflux disease (GERD) patients undergoing upper endoscopy.
Balasubramanian G; Singh M; Gupta N; Gaddam S; Giacchino M; Wani SB; Moloney B; Higbee AD; Rastogi A; Bansal A; Sharma P
Am J Gastroenterol; 2012 Nov; 107(11):1655-61. PubMed ID: 23032983
[TBL] [Abstract][Full Text] [Related]
6. Lack of differential pattern in central adiposity and metabolic syndrome in Barrett's esophagus and gastroesophageal reflux disease.
Healy LA; Ryan AM; Pidgeon G; Ravi N; Reynolds JV
Dis Esophagus; 2010 Jul; 23(5):386-91. PubMed ID: 20353443
[TBL] [Abstract][Full Text] [Related]
7. Associations of diabetes mellitus, insulin, leptin, and ghrelin with gastroesophageal reflux and Barrett's esophagus.
Rubenstein JH; Morgenstern H; McConell D; Scheiman JM; Schoenfeld P; Appelman H; McMahon LF; Kao JY; Metko V; Zhang M; Inadomi JM
Gastroenterology; 2013 Dec; 145(6):1237-44.e1-5. PubMed ID: 23999171
[TBL] [Abstract][Full Text] [Related]
8. Serum adiponectin, resistin, leptin concentration and central adiposity parameters in Barrett's esophagus patients with and without intestinal metaplasia in comparison to healthy controls and patients with GERD.
Mokrowiecka A; Daniel P; Jasinska A; Pietruczuk M; Pawlowski M; Szczesniak P; Orszulak-Michalak D; Malecka-Panas E
Hepatogastroenterology; 2012; 59(120):2395-9. PubMed ID: 22944288
[TBL] [Abstract][Full Text] [Related]
9. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.
Shaheen N; Ransohoff DF
JAMA; 2002 Apr; 287(15):1972-81. PubMed ID: 11960540
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Barrett's esophagus among men.
Rubenstein JH; Morgenstern H; Appelman H; Scheiman J; Schoenfeld P; McMahon LF; Metko V; Near E; Kellenberg J; Kalish T; Inadomi JM
Am J Gastroenterol; 2013 Mar; 108(3):353-62. PubMed ID: 23318485
[TBL] [Abstract][Full Text] [Related]
11. Fat mass by bioelectrical impedance analysis is not associated with increased risk of Barrett esophagus.
Thrift AP; Kramer JR; Alsarraj A; El-Serag HB
J Clin Gastroenterol; 2014 Mar; 48(3):218-23. PubMed ID: 23842216
[TBL] [Abstract][Full Text] [Related]
12. Gastroesophageal Reflux Frequency, Severity, Age of Onset, Family History and Acid Suppressive Therapy Predict Barrett Esophagus in a Large Population.
Bakr O; Zhao W; Corley D
J Clin Gastroenterol; 2018; 52(10):873-879. PubMed ID: 29356784
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications.
Hampel H; Abraham NS; El-Serag HB
Ann Intern Med; 2005 Aug; 143(3):199-211. PubMed ID: 16061918
[TBL] [Abstract][Full Text] [Related]
14. Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians.
Shaheen NJ; Weinberg DS; Denberg TD; Chou R; Qaseem A; Shekelle P;
Ann Intern Med; 2012 Dec; 157(11):808-16. PubMed ID: 23208168
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome and risk of ovarian and fallopian tube cancer in the United States: An analysis of linked SEER-Medicare data.
Michels KA; McNeel TS; Trabert B
Gynecol Oncol; 2019 Nov; 155(2):294-300. PubMed ID: 31495456
[TBL] [Abstract][Full Text] [Related]
16. Smokeless Tobacco and Cigar and/or Pipe Are Risk Factors for Barrett Esophagus in Male Patients With Gastroesophageal Reflux Disease.
Westra WM; Lutzke LS; Mostafavi NS; Roes AL; Calpe S; Wang KK; Krishnadath KK
Mayo Clin Proc; 2018 Sep; 93(9):1282-1289. PubMed ID: 30193675
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for Barrett's esophagus among patients with gastroesophageal reflux disease: a community clinic-based case-control study.
Edelstein ZR; Bronner MP; Rosen SN; Vaughan TL
Am J Gastroenterol; 2009 Apr; 104(4):834-42. PubMed ID: 19319131
[TBL] [Abstract][Full Text] [Related]
18. Abdominal obesity and body mass index as risk factors for Barrett's esophagus.
Corley DA; Kubo A; Levin TR; Block G; Habel L; Zhao W; Leighton P; Quesenberry C; Rumore GJ; Buffler PA
Gastroenterology; 2007 Jul; 133(1):34-41; quiz 311. PubMed ID: 17631128
[TBL] [Abstract][Full Text] [Related]
19. Association between metabolic syndrome and prevalence of gastroesophageal reflux disease in a health screening facility in Japan.
Niigaki M; Adachi K; Hirakawa K; Furuta K; Kinoshita Y
J Gastroenterol; 2013 Apr; 48(4):463-72. PubMed ID: 22976934
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of the association of low plasma adiponectin and Barrett's esophagus.
Rubenstein JH; Dahlkemper A; Kao JY; Zhang M; Morgenstern H; McMahon L; Inadomi JM
Am J Gastroenterol; 2008 Jun; 103(6):1358-64. PubMed ID: 18510610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
